Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα

Alioua, 1995, PKG-I alpha phosphorylates the alpha-subunit and upregulates reconstituted GKCa channels from tracheal smooth muscle, Am. J. Physiol., 268, L1057 Alioua, 1998, The large conductance, voltage-dependent, and calcium-sensitive K+ channel, Hslo, is a target of cGMP-dependent protein kinase phosphorylation in vivo, J. Biol. Chem., 273, 32950, 10.1074/jbc.273.49.32950 Bian, 2007, Nitric oxide signaling in vascular biology, J. Am. Soc. Hypertens., 1, 17, 10.1016/j.jash.2006.11.007 Borysova, 2015, Evidence that NO/cGMP/PKG signalling cascade mediates endothelium dependent inhibition of IPR mediated Ca oscillations in myocytes and pericytes of ureteric microvascular network in situ, Cell Calcium, 58, 535, 10.1016/j.ceca.2015.08.006 Brayden, 1992, Regulation of arterial tone by activation of calcium-dependent potassium channels, Science, 256, 532, 10.1126/science.1373909 Bryan, 2009, Discovery of the nitric oxide signaling pathway and targets for drug development, Front. Biosci., 14, 1, 10.2741/3228 Butt, 2009, cGMP-dependent protein kinase modulators, Handb. Exp. Pharmacol., 191, 409, 10.1007/978-3-540-68964-5_17 Carrier, 1997, Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels, Am. J. Physiol., 273, H76 Dora, 2001, Endothelial cell protein kinase G inhibits release of EDHF through a PKG-sensitive cation channel, Am. J. Physiol. Heart Circ. Physiol., 280, H1272, 10.1152/ajpheart.2001.280.3.H1272 Dostmann, 1999, Delineation of selective cyclic GMP-dependent protein kinase Ialpha substrate and inhibitor peptides based on combinatorial peptide libraries on paper, Pharmacol. Ther., 82, 373, 10.1016/S0163-7258(98)00063-1 Dostmann, 2000, Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation, Proc. Natl. Acad. Sci. USA, 97, 14772, 10.1073/pnas.97.26.14772 Earley, 2004, Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries, Circ. Res., 95, 922, 10.1161/01.RES.0000147311.54833.03 Evgenov, 2006, NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential, Nat. Rev. Drug Discov., 5, 755, 10.1038/nrd2038 Feil, 1993, High-level expression of functional cGMP-dependent protein kinase using the baculovirus system, FEBS Lett., 336, 163, 10.1016/0014-5793(93)81632-A Feil, 1995, Functional cGMP-dependent protein kinase is phosphorylated in its catalytic domain at threonine-516, Biochemistry, 34, 13152, 10.1021/bi00040a029 Feil, 2002, Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms, Circ. Res., 90, 1080, 10.1161/01.RES.0000019586.95768.40 Francis, 1988, Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase, Mol. Pharmacol., 34, 506 Francis, 2010, cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action, Pharmacol. Rev., 62, 525, 10.1124/pr.110.002907 Hofmann, 1995, The protein kinase facts book, 73 Hofmann, 2009, cGMP regulated protein kinases (cGK), Handb. Exp. Pharmacol., 191, 137, 10.1007/978-3-540-68964-5_8 Hofmann, 2014, L-type CaV1.2 calcium channels: from in vitro findings to in vivo function, Physiol. Rev., 94, 303, 10.1152/physrev.00016.2013 Huang, 1993, Endothelial dysfunction augments myogenic arteriolar constriction in hypertension, Hypertension, 22, 913, 10.1161/01.HYP.22.6.913 Jiang, 1992, Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries, J. Biol. Chem., 267, 1015, 10.1016/S0021-9258(18)48388-3 Kawada, 1997, cGMP-kinase mediates cGMP- and cAMP-induced Ca2+ desensitization of skinned rat artery, Eur. J. Pharmacol., 323, 75, 10.1016/S0014-2999(97)00028-9 Kemp-Harper, 2009, cGMP in the vasculature, Handb. Exp. Pharmacol., 191, 447, 10.1007/978-3-540-68964-5_19 Kennedy, 2015, Selective disruption of the AKAP signaling complexes, Methods Mol. Biol., 1294, 137, 10.1007/978-1-4939-2537-7_11 Kots, 2011, Nitric oxide and cyclic GMP signaling pathway as a focus for drug development, Curr. Med. Chem., 18, 3299, 10.2174/092986711796504646 Kuhn, 2003, Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A, Circ. Res., 93, 700, 10.1161/01.RES.0000094745.28948.4D Landgraf, 1991, Oxidation of cysteines activates cGMP-dependent protein kinase, J. Biol. Chem., 266, 16305, 10.1016/S0021-9258(18)55297-2 Lesh, 1995, Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle, Circ. Res., 77, 220, 10.1161/01.RES.77.2.220 Lincoln, 1977, Purification and subunit composition of guanosine 3′:5′-monophosphate-dependent protein kinase from bovine lung, J. Biol. Chem., 252, 4269, 10.1016/S0021-9258(17)40260-2 Moon, 2013, The Switch Helix: a putative combinatorial relay for interprotomer communication in cGMP-dependent protein kinase, Biochemica Biophys. Acta, 1834, 1346, 10.1016/j.bbapap.2013.02.009 Nelson, 1995, Relaxation of arterial smooth muscle by calcium sparks, Science, 270, 633, 10.1126/science.270.5236.633 Nickl, 2010, (D)-Amino acid analogues of DT-2 as highly selective and superior inhibitors of cGMP-dependent protein kinase Ialpha, Biochim. Biophys. Acta, 1804, 524, 10.1016/j.bbapap.2009.12.004 Orstavik, 1997, Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1), Genomics, 42, 311, 10.1006/geno.1997.4743 Osborne, 2011, Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication, Structure, 19, 1317, 10.1016/j.str.2011.06.012 Pfeifer, 1999, Structure and function of cGMP-dependent protein kinases, Rev. Physiol. Biochem. Pharmacol., 135, 105, 10.1007/BFb0033671 Potter, 2009, Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications, Handb. Exp. Pharmacol., 191, 341, 10.1007/978-3-540-68964-5_15 Robertson, 1993, cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells, Am. J. Physiol., 265, C299, 10.1152/ajpcell.1993.265.1.C299 Ruth, 1991, The activation of expressed cGMP-dependent protein kinase isozymes I alpha and I beta is determined by the different amino-termini, Eur. J. Biochem., 202, 1339, 10.1111/j.1432-1033.1991.tb16509.x Ruth, 1997, Identification of the amino acid sequences responsible for high affinity activation of cGMP kinase Ialpha, J. Biol. Chem., 272, 10522, 10.1074/jbc.272.16.10522 Salloum, 2012, Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide, Am. J. Physiol. Heart Circ. Physiol., 302, H1347, 10.1152/ajpheart.00544.2011 Sandberg, 1989, Molecular cloning and predicted full-length amino acid sequence of the type I beta isozyme of cGMP-dependent protein kinase from human placenta. Tissue distribution and developmental changes in rat, FEBS Lett., 255, 321, 10.1016/0014-5793(89)81114-7 Sausbier, 2000, Mechanisms of NO/cGMP-dependent vasorelaxation, Circ. Res., 87, 825, 10.1161/01.RES.87.9.825 Schasfoort, 2008 Schlossmann, 2005, cGMP-dependent protein kinases in drug discovery, Drug Discov. Today, 10, 627, 10.1016/S1359-6446(05)03406-9 Scholten, 2007, The hinge region operates as a stability switch in cGMP-dependent protein kinase I alpha, FEBS J., 274, 2274, 10.1111/j.1742-4658.2007.05764.x Schubert, 2001, Protein kinases: tuners of the BKCa channel in smooth muscle, Trends Pharmacol. Sci., 22, 505, 10.1016/S0165-6147(00)01775-2 Schwede, 2000, Cyclic nucleotide analogs as biochemical tools and prospective drugs, Pharmacol. Ther., 87, 199, 10.1016/S0163-7258(00)00051-6 Sun, 1994, Characteristics and origin of myogenic response in isolated gracilis muscle arterioles, Am. J. Physiol., 266, H1177 Tegge, 2010, Synthesis of peptides from alpha- and beta-tubulin containing glutamic acid side-chain linked oligo-glu with defined length, Int. J. Peptides, 2010, 189396, 10.1155/2010/189396 Wang, 2015, PKA-Type I selective constrained peptide disruptors of AKAP complexes, ACS Chem. Biol., 10, 1502, 10.1021/acschembio.5b00009 Wellman, 1996, A proposed mechanism for the cardioprotective effect of oestrogen in women: enhanced endothelial nitric oxide release decreases coronary artery reactivity, Clin. Exp. Pharmacol. Physiol., 23, 260, 10.1111/j.1440-1681.1996.tb02608.x Wernet, 1989, The cDNA of the two isoforms of bovine cGMP-dependent protein kinase, FEBS Lett., 251, 191, 10.1016/0014-5793(89)81453-X Wu, 1998, Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase, J. Biol. Chem., 273, 11362, 10.1074/jbc.273.18.11362 Zimmermann, 1997, Increased myogenic tone and diminished responsiveness to ATP-sensitive K+ channel openers in cerebral arteries from diabetic rats, Circ. Res., 81, 996, 10.1161/01.RES.81.6.996